It is recommended to avoid post-operative acute pain.(Evidence: Level B，Recommendation: Class I)

In order to minimize the risk of post-operative organ dysfunction, it is recommended to avoid an intra-operative mean arterial pressure decrease of .20% from baseline values or,60–70 mmHg for ≥10 min.(Evidence: Level B，Recommendation: Class I)

Non-aspirin NSAIDs are not recommended as first-line analgesics in patients with established or high risk of CVD.(Evidence: Level B，Recommendation: Class III)

It is recommended to have high awareness of peri-operative CV complications, combined with surveillance for PMI in patients undergoing intermediate- or high-risk NCS. (Evidence: Level B，Recommendation: Class I)

Systematic PMI work-up is recommended to identify the underlying pathophysiology and define therapy. (Evidence: Level B，Recommendation: Class Ⅰ)

It is recommended to treat post-operative STEMI, NSTE-ACS, acute HF, and tachyarrhythmias in accordance with guidelines for the non-surgical setting, after interdisciplinary discussion with the surgeon about bleeding risk. (Level of evidence：C；Class of recommendation：I）

In patients with post-operative PE of high or intermediate clinical probability, initiation of anticoagulation is recommended without delay, while diagnostic work-up is in progress, if bleeding risk is low. (Evidence: Level C，Recommendation: Class Ⅰ)

Post-operative oral anticoagulation for PE is recommended to be administered for a period of at least 3 months. (Level of evidence：C；Class of recommendation：I）

In patients with a post-operative indication for OAC, NOAC is generally recommended over VKA.9. (Evidence: Level A ，Recommendation: Class I)

In patients with post-operative AF after NCS, long-term OAC therapy should be considered in all patients at risk of stroke, considering the anticipated net clinical benefit of OAC therapy, and informed patient preferences. (Evidence: Level B，Recommendation: Class IIa)